Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2013 Feb;120(2):144-7.
doi: 10.1016/j.ijgo.2012.08.017. Epub 2012 Dec 20.

Institutional prevention policies and rates of Group B Streptococcus infection among HIV-infected pregnant women and their infants in Latin America

Esaú Joao  1 , Maria I Gouvea, Laura Freimanis-Hance, Rachel A Cohen, Jennifer S Read, Victor Melo, Geraldo Duarte, Silvina Ivalo, Daisy M Machado, Jose Pilotto, George K Siberry; NISDI/LILAC Protocol
Affiliations

Institutional prevention policies and rates of Group B Streptococcus infection among HIV-infected pregnant women and their infants in Latin America

Esaú Joao et al. Int J Gynaecol Obstet. 2013 Feb.

Abstract

Objective: To describe Group B Streptococcus (GBS) prevention policies at 12 Latin American sites participating in the NICHD (Eunice Kennedy Shriver National Institute of Child Health and Human Development) International Site Development Initiative (NISDI) Longitudinal Study in Latin American Countries (LILAC) and to determine rates of rectovaginal colonization and GBS-related disease among HIV-infected pregnant women and their infants.

Methods: Site surveys were used to assess prevention policies and practices administered cross-sectionally during 2010. Data collected in NISDI from 2008 to 2010 regarding HIV-infected pregnant women were used to determine rates of colonization and GBS-related disease.

Results: Of the 9 sites with a GBS prevention policy, 7 performed routine rectovaginal screening for GBS. Of the 401 women included in the NISDI study, 56.9% were at sites that screened. The GBS colonization rate was 8.3% (19/228 women; 95% confidence interval [CI], 5.1%-12.7%). Disease related to GBS occurred in 0.5% of the participants (2/401 women; 95% CI, 0.1%-1.8%); however, no GBS-related disease was reported among the 398 infants (95% CI, 0.0%-0.9%).

Conclusion: Improved efforts to implement prevention policies and continued surveillance for GBS are needed to understand the impact of GBS among HIV-infected pregnant women and their infants in Latin America.

PubMed Disclaimer

Conflict of interest statement

Conflict of interest

The authors have no conflicts of interest.

References

    1. Verani JR, McGee L, Schrag SJ Division of Bacterial Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention (CDC) Prevention of perinatal group B streptococcal disease--revised guidelines from CDC, 2010. MMWR Recomm Rep. 2010;59(RR-10):1–36. - PubMed
    1. Edwards MS, Baker CJ. Streptococcus Agalactiae. In: Mandell GL, Bennett JE, Dolin R, editors. Principles and Practice of Infectious Diseases. 7. Vol. 2. Philadelphia: Churchill Livingstone Elsevier; 2010. pp. 2655–66.
    1. El Beitune P, Duarte G, Maffei CM, Quintana SM, De Sá Rosa E, Silva AC, Nogueira AA. Group B Streptococcus carriers among HIV-1 infected pregnant women: prevalence and risk factors. Eur J Obstet Gynecol Reprod Biol. 2006;128(1–2):54–8. - PubMed
    1. Epalza C, Goetghebuer T, Hainaut M, Prayez F, Barlow P, Dediste A, et al. High incidence of invasive group B streptococcal infections in HIV-exposed uninfected infants. Pediatrics. 2010;126(3):e631–8. - PubMed
    1. Joao EC, Gouvêa MI, Menezes JA, Matos HJ, Cruz ML, Rodrigues CA, et al. Group B Streptococcus in a cohort of HIV-infected pregnant women: prevalence of colonization, identification and antimicrobial susceptibility profile. Scand J Infect Dis. 2011;43(9):742–6. - PubMed

Publication types